![COVID-19 Vaccines](https://public4.pagefreezer.com:443/content/FDA/28-02-2023T11:22/http://www.fda.gov/files/styles/medium_3/public/2020-12-10-covid-hero-graphicv2_0.jpg?itok=w67T1LIp)
Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
The FDA’s multipronged response to monkeypox (mpox) includes efforts in the areas of diagnostics, vaccines and therapeutics.
FDA works closely with manufacturers to prevent or reduce the impact of drug shortages.
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Feb 01
Cosmetics, Food & Beverages
Feb 01
Food & Beverages
Jan 31
Drugs
In 2022, CDER approved 37 new drugs never before approved or marketed in the U.S., known as “novel” drugs.
LMAP lays out our plans to strengthen our technology leadership capabilities to drive change at the business, technology, data, and cybersecurity levels.
CMAP will leverage Artificial Intelligence and Machine Learning technologies to enhance cyber detection and response capabilities.
Feb 01
Drugs
Jan 31
Drugs
Jan 31
Radiation-Emitting Products